The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ERIC 2018 | Looking to the future in CLL treatment
Looking to the future in chronic lymphocytic leukemia (CLL) treatment, John Seymour, MBBS, PhD, of the Peter MacCallum Cancer Center, Victoria, Australia, discusses his thoughts on the most promising directions for deep responses that are both economical and well tolerated, including the combination of BTK and BCL-2 inhibitors. This video was recorded at the European Research Initiative on CLL (ERIC) International Meeting 2018, held in Barcelona, Spain.
